As shown in Figure 5A, the patients with a low CD3+ TIL density and a high CD24 expression in tumor cells emerged as a subgroup with the shortest survival, with median DFS and MFS of 2.6 and 3.9 years, respectively (Figure 5A). The gene discussed is CD24; the disease is neoplasm.